A Clinical Effect Study On The Shugan Benefiting Kidney Decoction In The Treatment Of Postmenopausal Osteoporosis

ObjectiveThis study is used to ShuGan oral benefiting kidney decoction in the treatment of postmenopausal osteoporosis patients, through the observation after treatment, patients with symptoms improved, and with pure western medicine therapy group, compared ShuGan observation benefiting kidney decoction in the treatment of postmenopausal osteoporosis curative effect, thus for postmenopausal osteoporosis treatments with more traditional Chinese medicine theory and clinical treatment.MethodsChoose between January2011and March2012in shenzhen baoan district hospital in hospital and clinic diagnosis of formulary postmenopausal osteoporosis patients, according to the criteria and exclusion standard, altogether collected60cases, according to the envelope method randomly divided into Chinese medicine therapy group and pure western medicine therapy group (control group), each group are30cases. The group intends to give ShuGan benefiting kidney soup Fried uniform, the control group give alendronate piece, method, and calcium capsule D3eq D oral, collection of data input statistical software, data analysis, concluded.Results1.two groups of participants in60patients, including30patients in the trial,30cases in, two groups in the average age, duration, bone mineral density differences both not significant (p>0.05), comparable.2.the two groups after6months of treatment, and patients completed28cases effectiveness and3cases, clinical the total effective rate was83.34%; The control group completed case,24cases were invalid in2cases, clinical the total effective rate was73.33%, the difference was not statistically significant (p>0.05), two groups of over all efficient quite.3. two groups before and after treatment, and patients fall off2cases and control fall off in6, two groups of loss rate comparing statistical significance, and the treatment group fall off rates lower than those in the control group.4. after6months of treatment, the two groups of VAS scores are significantly reduced, the difference was statistically significant (p<0.05), shows two groups of treatment methods are effective improve patients’pain core symptoms, Comparison between the two groups, baseline treatment group VAS score when compared with the difference was not statistically significant (p>0.05), comparable in the treatment of6months, rated slightly lower than those of the control group, but the difference was not statistically significant (p>0.05), with a control group group curative effect.5. after treatment, two groups of bone mineral density (BMD) increased, and contrast before treatment, the difference was statistically significant (p <0.05), shows two groups of treatment methods are patients with significantly increased bone mineral content. Before treatment and treatment after march group and control group bone mineral density (BMD) between comparison, there were no statistically significant difference (p>0.05), with a control group group curative effect.ConclusionShuGan benefiting kidney soup can better improve postmenopausal osteoporosis women pain symptoms and core bone mineral density, the total effective and simple clinical treatment of western quite, but Chinese medicine diagnosis and treatment rate was significantly lower than the control group fall off, consider possible reason is ShuGan TCM benefiting kidney therapy can manage liver and kidney, cultivates the solid yuan, comprehensive regulate, has little side effect, compliance higher advantage, can be in clinical to further promote the use.